medicare and glp 1 coverage Navigating Changes to GLP-1 Medication A Cost That's Hard to

4,107 These findings are further supported by RCTs in older adults demonstrating that dietary weight loss alone leads to a decline in BMD, while control groups maintain stable bone mass

The global GLP-1 receptor agonist market is rapidly expanding due to the rising prevalence of type 2 diabetes and obesity, which have become major public health concerns

Board-certified physician oversight catches problems early and optimizes treatment throughout the process

Driscoll AK et al

Acknowledgments We would like to thank Mohammed Asker for performing the tissue collection and RT-PCR gene expression assay of the gastrointestinal tract

10.1056/NEJMoa2206038 [DOI] [PubMed] [Google Scholar] 42